George Georgiou

George Georgiou

Auto-generated profile, based on publicly available information

George Georgiou

Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2020 in Science
Verified
Journal Article
Closed access
PDF file
MBMichael A. Badgley
Michael A. Badgley
DKDaniel M. Kremer
Daniel M. Kremer
HMH. Carlo Maurer
H. Carlo Maurer
KDKathleen E. DelGiorno
Kathleen E. DelGiorno
HLHo-Joon Lee
Ho-Joon Lee
KOKenneth P. Olive
Kenneth P. Olive
Ferroptotic cell death and cancer: Cell death can occur through different mechanisms, several of which are being explored as potential targets for cancer treatment. One form of cell death that has attracted recent interest is ferroptosis, which is triggered by high intracellular levels of lipid reactive oxygen species. Pancreatic cancer cells have high levels of reactive oxygen species but manage to avoid ferroptosis by importing extracellular cysteine. Studying mice bearing pancreatic tumors, Badgley et al. found that administration of a drug inhibiting cysteine import induced tumor-selective ferroptosis and inhibited tumor growth. Further work will be required to determine whether this therapeutic strategy will be effective in human pancreatic cancer, a tumor type for which new treatments are urgently needed. Science , this issue p. 85

19 January 2014 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
GGGeorge Georgiou
George Georgiou
Gregory C. IppolitoGregory C. Ippolito
Gregory C. Ippolito
JBJohn Beausang
John Beausang
CBChristian E Busse
Christian E Busse
HWHedda Wardemann
Hedda Wardemann
SQStephen R Quake
Stephen R Quake

23 November 1999 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
PBPaul H. Bessette
Paul H. Bessette
FÅFredrik Åslund
Fredrik Åslund
JBJon Beckwith
Jon Beckwith
GGGeorge Georgiou
George Georgiou
Under physiological conditions, the Escherichia coli cytoplasm is maintained in a reduced state that strongly disfavors the formation of stable disulfide bonds in proteins. However, mutants in which the reduction of both thioredoxins and glutathione is impaired ( trxB gor mutants) accumulate oxidized, enzymatically active alkaline phosphatase in the cytoplasm. These mutants grow very poorly in the absence of an exogenous reductant and accumulate extragenic suppressors at a high frequency. One such suppressor strain, FA113, grows almost as rapidly as the wild type in the absence of reductant, exhibits slightly faster kinetics of disulfide bond formation, and has fully induced activity of the transcriptional activator, OxyR. FA113 gave substantially higher yields of properly oxidized proteins compared with wild-type or trxB mutant strains. For polypeptides with very complex patterns of disulfide bonds, such as vtPA and the full-length tPA, the amount of active protein was further enhanced up to 15-fold by co-expression of TrxA (thioredoxin 1) mutants with different redox potentials, or 20-fold by the protein disulfide isomerase, DsbC. Remarkably, higher yields of oxidized, biologically active proteins were obtained by expression in the cytoplasm of E. coli FA113 compared with what could be achieved via secretion into the periplasm of a wild-type strain, even under optimized conditions. These results demonstrate that the cytoplasm can be rendered sufficiently oxidizing to allow efficient formation of native disulfide bonds without compromising cell viability.

21 November 2016 in Nature Medicine
Verified
Journal Article
Open access
PDF file
SCShira L Cramer
Shira L Cramer
ASAchinto Saha
Achinto Saha
JLJinyun Liu
Jinyun Liu
STSurendar Tadi
Surendar Tadi
STStefano Tiziani
Stefano Tiziani
ESEverett Stone
Everett Stone
By reducing the availability of extracellular L-cyst(e)ine, an engineered enzyme inhibits glutathione production and cripples antioxidant defenses of tumors in a variety of mouse models. Cancer cells experience higher oxidative stress from reactive oxygen species (ROS) than do non-malignant cells because of genetic alterations and abnormal growth; as a result, maintenance of the antioxidant glutathione (GSH) is essential for their survival and proliferation1,2,3. Under conditions of elevated ROS, endogenous L-cysteine (L-Cys) production is insufficient for GSH synthesis. This necessitates uptake of L-Cys that is predominantly in its disulfide form, L-cystine (CSSC), via the xCT(−) transporter. We show that administration of an engineered and pharmacologically optimized human cyst(e)inase enzyme mediates sustained depletion of the extracellular L-Cys and CSSC pool in mice and non-human primates. Treatment with this enzyme selectively causes cell cycle arrest and death in cancer cells due to depletion of intracellular GSH and ensuing elevated ROS; yet this treatment results in no apparent toxicities in mice even after months of continuous treatment. Cyst(e)inase suppressed the growth of prostate carcinoma allografts, reduced tumor growth in both prostate and breast cancer xenografts and doubled the median survival time of TCL1-Tg:p53−/− mice, which develop disease resembling human chronic lymphocytic leukemia. It was observed that enzyme-mediated depletion of the serum L-Cys and CSSC pool suppresses the growth of multiple tumors, yet is very well tolerated for prolonged periods, suggesting that cyst(e)inase represents a safe and effective therapeutic modality for inactivating antioxidant cellular responses in a wide range of malignancies4,5.

20 January 2013 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
BDBrandon J DeKosky
Brandon J DeKosky
Gregory C. IppolitoGregory C. Ippolito
Gregory C. Ippolito
RDRyan P Deschner
Ryan P Deschner
JLJason J Lavinder
Jason J Lavinder
YWYariv Wine
Yariv Wine
GGGeorge Georgiou
George Georgiou

1 January 1997 in Nature Biotechnology
Verified
Journal Article
Closed access
GGGeorge Georgiou
George Georgiou
CSChristos Stathopoulos
Christos Stathopoulos
PDPatrick S. Daugherty
Patrick S. Daugherty
ANAmiya R. Nayak
Amiya R. Nayak
BIBrent L. Iverson
Brent L. Iverson
RIRoy Curtiss Iii
Roy Curtiss Iii